Speculative BUY alert on BRNE - is set to copy last weeks soar
BRNE - got wings last week on tremendous volume build-up. Soared over a 1000% from $ 0.002 to over $0.017.
The stock never came back to its earlier levels. On the contrary, it started retrace over and over again from $0.003 (+50% from last weeks level) to +$0.004.
The week ended in intensive more volume and @$0.0042. This will not go without being noticed by the many volume screeners and penstock speculators on Monday.
First estimate on volume boosts is the $0.006 level (+33%) then $0.01 (+150%). Everything else above these levels is bonus.
Chances are the situation from last Monday will be overdone.
NOTE: Pennystock or Pinksheet trading/investing is very speculative and can lead to extreme loss of your invested money. This is not an advice rather then it is an idea on my personal due diligence. Before taking any trade it is strongly advised to do your own studying in what you invest. I am a holder of the value myself at an average of $0.0032 USD per share.
The stock never came back to its earlier levels. On the contrary, it started retrace over and over again from $0.003 (+50% from last weeks level) to +$0.004.
The week ended in intensive more volume and @$0.0042. This will not go without being noticed by the many volume screeners and penstock speculators on Monday.
First estimate on volume boosts is the $0.006 level (+33%) then $0.01 (+150%). Everything else above these levels is bonus.
Chances are the situation from last Monday will be overdone.
NOTE: Pennystock or Pinksheet trading/investing is very speculative and can lead to extreme loss of your invested money. This is not an advice rather then it is an idea on my personal due diligence. Before taking any trade it is strongly advised to do your own studying in what you invest. I am a holder of the value myself at an average of $0.0032 USD per share.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.